Sharecare (SHCR) Competitors

Sharecare (NASDAQ:SHCR) and GeneDx (NASDAQ:WGS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

Does the media refer more to SHCR or WGS?

In the previous week, Sharecare had 6 more articles in the media than GeneDx. MarketBeat recorded 9 mentions for Sharecare and 3 mentions for GeneDx. GeneDx's average media sentiment score of 0.57 beat Sharecare's score of 0.03 indicating that GeneDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sharecare	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
GeneDx	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, SHCR or WGS?

Sharecare has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500. Comparatively, GeneDx has a beta of 2.75, indicating that its stock price is 175% more volatile than the S&P 500.

Which has higher valuation & earnings, SHCR or WGS?

Sharecare has higher revenue and earnings than GeneDx. Sharecare is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sharecare	$445.25M	0.50	-$128.50M	-$0.37	-1.69
GeneDx	$202.57M	1.23	-$175.77M	-$7.44	-1.28

Do insiders and institutionals hold more shares of SHCR or WGS?

35.1% of Sharecare shares are owned by institutional investors. Comparatively, 61.7% of GeneDx shares are owned by institutional investors. 29.3% of Sharecare shares are owned by insiders. Comparatively, 28.1% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community prefer SHCR or WGS?

Sharecare received 6 more outperform votes than GeneDx when rated by MarketBeat users. Likewise, 35.29% of users gave Sharecare an outperform vote while only 0.00% of users gave GeneDx an outperform vote.

Company	Underperform	Outperform
Sharecare	Outperform Votes 6 35.29%	Underperform Votes 11 64.71%
GeneDx	Outperform Votes No Votes	Underperform Votes 4 100.00%

Do analysts rate SHCR or WGS?

Sharecare presently has a consensus price target of $1.00, suggesting a potential upside of 58.28%. GeneDx has a consensus price target of $11.00, suggesting a potential upside of 15.06%. Given Sharecare's higher probable upside, analysts clearly believe Sharecare is more favorable than GeneDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharecare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
GeneDx	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Is SHCR or WGS more profitable?

Sharecare has a net margin of -28.86% compared to GeneDx's net margin of -86.77%. Sharecare's return on equity of -17.11% beat GeneDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sharecare	-28.86%	-17.11%	-12.33%
GeneDx	-86.77%	-49.64%	-29.57%

Summary

Sharecare beats GeneDx on 11 of the 16 factors compared between the two stocks.